Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 41,600 VNDA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 41,600 | n/a |
| Feb 24, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 30,000 | $240.9K |
| Jun 9, 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 59,225 | n/a |
| May 21, 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 20,529 | n/a |
| Jun 12, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 17,307 | n/a |
| Mar 17, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 26,408 | n/a |